title: Managed care in benign gynecology.
abstract: The invasion of managed care into the American health system has led to drastic and potentially salutary changes in both the locus and delivery of care. With a focus on cost-effectiveness and decisions based on outcomes analysis, the rationale of many traditional management options has been called into question. A discussion of how the implementation of this new evidence-based, cost-centered gold standard has affected the management of four benign gynecologic processes is the purpose of this update.
authors.affiliation: Gynecologic Oncology Service, Jonsson Comprehensive Cancer Center, University of California Los Angeles Center for Health Sciences 90095, USA.
authors.forename: F J
authors.initials: FJ
authors.lastname: Montz
mesh_terms: D003362:Cost-Benefit Analysis; D019317:Evidence-Based Medicine; D005260:Female; D005831:Genital Diseases, Female / Q000175:diagnosis* / Q000628:therapy*; D006176:Gynecology / Q000458:organization & administration*; D006801:Humans; D015907:Hysteroscopy; D010535:Laparoscopy; D008329:Managed Care Programs / Q000458:organization & administration*; D017063:Outcome Assessment, Health Care